Aniracetam, also known as Ampamet and Ro-13-5057, is a pyrrolidinone-type cognition enhancer that has been clinically used in the treatment of behavioral and psychological symptoms of dementia following stroke and in Alzheimer's disease. Aniracetam appears to positively modulate metabotropic glutamate receptors and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-sensitive glutamate receptors, and may facilitate cholinergic transmission, effects which are possibly related to its mechanism of action.
Properties:
Appearance & Physical State: White Crystalline or Crystalline Powde
Density: 1.236 g/cm3
Boiling Point: 399.7ºC at 760 mmHg
Melting Point: 119-122ºC
Flash Point: 195.5ºC
Refractive Index: 1.573
Vapor Density: 4.9